Orphazyme A/S Profit Margin

Orphazyme A/S posts a profit margin of -Infinity% as of June 2024. That compares with -24.87% in the prior-year period — down Infinity% year over year. That is below the Healthcare sector average of 15.52%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Orphazyme A/S's profit margin was -24.87%. The latest reading is -Infinity% — a Infinity% year-over-year decrease (period ending June 2024). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 15.52% is typical. Orphazyme A/S's -Infinity% is lower that level. That is roughly Infinity% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Orphazyme A/S's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -Infinity% as of June 2024; use YoY and peer views to separate noise from signal.

Context for ORPH's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 15.52%), and (3) consistency with growth and profitability. This page covers the first two; Orphazyme A/S's other metric pages and overview cover the third.